ATNM Stock Analysis: Buy, Sell, or Hold?
ATNM - Actinium Pharmaceuticals, Inc
$1.30
0.05 (4.00%)
▲
5d:
+20.37%
30d:
+18.18%
90d:
-0.76%
HOLD
MODERATE Confidence
Analysis Updated: Apr 17, 2026 12:00 AM ET
Earnings: May 08, 2026
18d
Get Alerted When ATNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ATNM is 9.2% above fair value ($1.19). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ATNM is 9.2% above fair value ($1.19). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ATNM is currently trading at $1.30, which is considered extended relative to its 30-day fair value range of $1.03 to $1.19.
Technical Outlook: Technically, ATNM is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.34. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: ATNM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.75 (+342.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATNM is in a strong downtrend. Immediate support is located at $1.01, while resistance sits at $1.34. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: ATNM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.75 (+342.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.03 -
$1.19
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+9.2% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 342.3% below Wall St target ($5.75)
- CAUTION: Extended 9.2% above fair value - wait for pullback
Fair Price Analysis
30-Day Fair Range
$1.03 -
$1.19
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.01
Resistance Level
$1.34
Current Trend
Strong Downtrend
Technical data as of
Apr 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.31
Wall Street Target
$5.75
(+342.3%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: April 19, 2026 9:29 AM ET
Data refreshes hourly during market hours. Next update: 10:29 AM
Data refreshes hourly during market hours. Next update: 10:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATNM showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$224 | 60 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 66 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 66 BUY |
